Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Mar 4, 2010

Beijing Pioneer to Provide Olink’s Duolink Product Line in China

  • Beijing Pioneer Medical Instrument negotiated a license to distribute Olink Bioscience’s Duolink® product line in China. Duolink products are based on Olink’s proximity ligation assay (PLA) technology for the in situ detection of proteins, protein interactions, and modification.

    The firm claims that the platform allows target protein detection at single molecule resolution, which means proteins can be studied at normal expression levels in fixed cells and tissue sections. The PLA technology features dual recognition of the analyte in combination with a DNA amplification-based reporter system. This results in unparalleled sensitivity and specificity, according to Olink.

     



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »